Patient Guide: Neoadjuvant Treatment With Atezolizumab and Atezolizumab as Maintenance for the Treatment of Stage III Non Small-Cell Lung Cancer (NSCLC)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 21 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT07153445
Status: 🟢 Enrolling Now
Condition: Non Small Cell Lung Cancer, Stage IIIA Lung Cancer, Stage IIIB Lung Cancer
Phase: PHASE2

Where You Can Participate

This study is available at 21 locations across the country.

Top locations include:
  • • Alicante, Alicante
  • • Badalona, Barcelona
  • • Barcelona, Barcelona
  • • And 18 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Neoadjuvant Treatment With Atezolizumab and Atezolizumab as Maintenance for the Treatment of Stage III Non Small-Cell Lung Cancer (NSCLC) - Join Clinical Trial NCTNCT07153445

How to Join This Clinical Trial - NCTNCT07153445

Learn how to participate in this PHASE2 trial studying an investigational therapy for Non Small Cell Lung Cancer, Stage IIIA Lung Cancer, Stage IIIB Lung Cancer. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Non Small Cell Lung Cancer, Stage IIIA Lung Cancer, Stage IIIB Lung Cancer. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Non Small Cell Lung Cancer, Stage IIIA Lung Cancer, Stage IIIB Lung Cancer
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT07153445 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 21 locations. Find a study site near you:

Clinical Research Site

Alicante, Alicante 03010 - Spain

Status: RECRUITING

Clinical Research Site

Badalona, Barcelona 08916 - Spain

Status: RECRUITING

Clinical Research Site

Barcelona, Barcelona 08035 - Spain

Status: NOT_YET_RECRUITING

Clinical Research Site

Barcelona, Barcelona 08041 - Spain

Status: NOT_YET_RECRUITING

Clinical Research Site

Barcelona, Barcelona 08208 - Spain

Status: NOT_YET_RECRUITING

Clinical Research Site

Bilbao, Bilbao 48013 - Spain

Status: RECRUITING

Clinical Research Site

Jerez de la Frontera, Cadiz 11407 - Spain

Status: NOT_YET_RECRUITING

Clinical Research Site

Girona, Girona 17007 - Spain

Status: RECRUITING

Clinical Research Site

Granada, Granada 18007 - Spain

Status: NOT_YET_RECRUITING

Clinical Research Site

Jaén, Jaén 23007 - Spain

Status: NOT_YET_RECRUITING

And 11 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Non Small Cell Lung Cancer, Stage IIIA Lung Cancer, Stage IIIB Lung Cancer:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships